These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 539926)

  • 1. [Experimental study of the cardiovascular action of propafenon].
    Sant'Anna JR; Mattos E; Belardinelli L; Lucchese FA
    Arq Bras Cardiol; 1979 Aug; 33(2):153-9. PubMed ID: 539926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic action of propafenon in patients with atherosclerotic coronary disease].
    Lamounier EN; Martinez Filho EE; Herrmann JL; Guimarães RD; Portugal OP; Barcellini A
    Arq Bras Cardiol; 1979 Jul; 33(1):73-6. PubMed ID: 526178
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
    Hapke HJ; Prigge E
    Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cathinones: cardiovascular and behavioral effects in rats and self-administration experiment in rhesus monkeys.
    Yanagita T
    NIDA Res Monogr; 1979; 27():326-7. PubMed ID: 121354
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correction of extracardiac effects on the heart as a method of treating ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Litvitskiĭ PF; Bragina GI
    Farmakol Toksikol; 1982; 45(3):53-9. PubMed ID: 6284550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of myocardial contractions in chronic coronary insufficiency and under the effects of oxyphedrine].
    Ferreira Montero I; González Carretero M; Del Rio Ligorit A; La Figuera Benito E
    Rev Esp Cardiol; 1974; 27(5):391-9. PubMed ID: 4456468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of propafenon on isometric contraction of isolated atrium in mammals].
    Vassallo DV; Mill JG; Futuro Neto Hde A
    Arq Bras Cardiol; 1979 Oct; 33(4):299-301. PubMed ID: 548000
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
    Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
    Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the mechanical action of the isolated guinea pig heart induced by doses of propafenon capable of affecting the electrocardiogram].
    Tucci PJ; Cicogna AC; Spadaro J
    Arq Bras Cardiol; 1979 Sep; 33(3):229-32. PubMed ID: 543812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacologic effects in combined use of oxyfedrine and beta-acetyldiogoxin].
    Stroman VF; Hempel R
    Arzneimittelforschung; 1975 Mar; 25(3):386-8. PubMed ID: 1174037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of propafenon in experimentally digitalis glycoside-induced arrhythmia].
    Germiniani H; Branco Germiniani CD; Iark FB; do Pillar MD
    Arq Bras Cardiol; 1979 Jul; 33(1):77-83. PubMed ID: 526179
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immediate action of oxyphedrin as evaluated using the exertion test in coronary patients].
    Velasco Rami JA; Tormo Alfonso V; Roda Nicolas J; Serra Sister E
    Rev Esp Cardiol; 1977; 30(1):17-21. PubMed ID: 854620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some advances in cardiovascular pharmacology (author's transl)].
    Ding GS
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):97-103. PubMed ID: 6118953
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differential effects of a new anti-arrhythmia agent (propafenon) on the Purkinje and myocardial activity filaments].
    Bolte HD; Bergmann M; Tebbe U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1239-42. PubMed ID: 1029968
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of atropine, propafenon and disopyramide on "sino-atrial conduction time" in man].
    Breithardt G; Seipel L; Both A; Loogen F
    Verh Dtsch Ges Inn Med; 1975; 81():1634-7. PubMed ID: 1227042
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.